Life must be monitored with frequent COVID-19 testing. Innova Medical Group believes students deserve a safe and engaging learning environment.
How do you keep students and staff protected and virus-free in schools as we return to on-site education?
Rapid, surveillance testing large numbers of students is the best way to fend off outbreaks on campuses and schools. With the availability and affordability of INNOVA’s rapid antigen test, schools can ramp up testing and stay ahead of COVID-19. About 40 percent of U.S. universities report having no testing plan or only a voluntary one with little follow up. Also, many schools rely on diagnostic testing, Polymerase Chain Reaction (PCR) of symptomatic students, but with limited lab space and delayed results, positive results come too late to control outbreaks. Symptom-based screening will not find asymptomatic cases and stop the likelihood of silent spreading. Rapid antigen testing, at least twice a week, can let students know their COVID-19 status and stop onward transmission.
The CDC believes that entry testing, before return to campus, combined with regular testing might prevent or reduce coronavirus transmission. But universities and schools need guidance to conduct massive testing and get results back quickly. Communities close to universities also need to understand real-time risk. Teachers and staff support must feel safe to return to work, rather than stay with remote learning.
With Innova’s recent success in the Operation Moonshot Liverpool pilot, the UK government plans to mass test students before they can return to campuses. The INNOVA SARS-CoV-2 Antigen Rapid Test can detect viral proteins on a machine-free, lateral flow assay, in as little as 15 minutes. Especially with the higher transmissibility of the new COVID-19 variant, testing can work to keep schools and universities operating.